About EPIBONE, INC.
Epibone is a biotechnology company focused on regenerating bone and cartilage using stem cells, offering personalized medical solutions that avoid the need for artificial implants or grafts. The company aims to address skeletal conditions through regenerative medicine.
Regeneration of bone and cartilage using stem cellsCreation of personalized anatomical shapes for implantsBioreactor technology for tissue growthAvoidance of immune rejection and implant degradation
Recent Federal Awards
| Award | Agency | Amount | Date |
|---|---|---|---|
| REGENERATING WARFIGHTER MOBILITY WITH EB-OC- A NEXT-GENERATION LIVING OSTEOCHONDRAL GRAFT TO TREAT COMBAT-ACQU | Department of Defense | $1.2M | |
| NEXT-GENERATION CRANIOFACIAL SURGERY: VALIDATING EPIBONE EB-CMF REGENERATIVE BONE GRAFTS FOR USE IN THE MAXILL | Department of Defense | $1.2M | |
| EPIBONE: SOLUTION TO PROVIDE BONE RECONSTRUCTION DUE TO BATTLEFIELD INJURY | Department of Defense | $75K | |
| SOLUTION TO PROVIDE CARTILAGE REPLACEMENT FOR LONG-TERM AND PROGRESSIVE USAGE | Department of Defense | $74K |
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to EPIBONE, INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.